These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 25874915)
1. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. Alberti S; Chiesa A; Andrisano C; Serretti A J Clin Psychopharmacol; 2015 Jun; 35(3):296-303. PubMed ID: 25874915 [TBL] [Abstract][Full Text] [Related]
2. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive review and meta-analysis of neurological side effects related to second-generation antidepressants in individuals with major depressive disorder. Zhou Q; Li X; Yang D; Xiong C; Xiong Z Behav Brain Res; 2023 Jun; 447():114431. PubMed ID: 37044221 [TBL] [Abstract][Full Text] [Related]
4. Severe diurnal somnolence induced by fluvoxamine-lithium combination. Marchesi C; Paini M; Maggini C Pharmacopsychiatry; 2005 May; 38(3):145-6. PubMed ID: 15902588 [No Abstract] [Full Text] [Related]
5. Daytime sleepiness and insomnia as correlates of depression. Fava M J Clin Psychiatry; 2004; 65 Suppl 16():27-32. PubMed ID: 15575802 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and tolerability of bupropion in the treatment of major depressive disorder. Moreira R Clin Drug Investig; 2011 Oct; 31 Suppl 1():5-17. PubMed ID: 22015858 [TBL] [Abstract][Full Text] [Related]
9. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani]. Gaillard R Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025 [TBL] [Abstract][Full Text] [Related]
11. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice. Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379 [TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis. Oliva V; Lippi M; Paci R; Del Fabro L; Delvecchio G; Brambilla P; De Ronchi D; Fanelli G; Serretti A Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110266. PubMed ID: 33549697 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder. Sheehan DV; Rozova A; Gossen ER; Gibertini M Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790 [TBL] [Abstract][Full Text] [Related]
14. Development of Insomnia Associated With Different Formulations of Bupropion. Gandotra K; Jaskiw GE; Williams SG; Fuller MA; Chen P; Wilson B; ElGhoul R; Konicki E; Strohl KP Prim Care Companion CNS Disord; 2021 Feb; 23(1):. PubMed ID: 34000136 [No Abstract] [Full Text] [Related]
15. Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis. Zhou S; Li P; Lv X; Lai X; Liu Z; Zhou J; Liu F; Tao Y; Zhang M; Yu X; Tian J; Sun F Sleep; 2023 Oct; 46(10):. PubMed ID: 37422714 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Nelson JC; Delucchi K; Schneider LS Am J Geriatr Psychiatry; 2008 Jul; 16(7):558-67. PubMed ID: 18591576 [TBL] [Abstract][Full Text] [Related]
17. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Gartlehner G; Hansen RA; Morgan LC; Thaler K; Lux L; Van Noord M; Mager U; Thieda P; Gaynes BN; Wilkins T; Strobelberger M; Lloyd S; Reichenpfader U; Lohr KN Ann Intern Med; 2011 Dec; 155(11):772-85. PubMed ID: 22147715 [TBL] [Abstract][Full Text] [Related]